Investigate the Safety,Tolerability and Pharmacodynamics of MEDI8111.

• Research type

  Research Study

• Full title

  A Phase 1, Single-blind, Randomised, Placebo-controlled, Single Centre Study to Investigate the Safety, Tolerability and Pharmacodynamics of Intravenous MEDI8111 after Single Ascending Doses in Healthy Male Subjects.

• IRAS ID

  138298

• Contact name

  Tim Mant

• Contact email

  tim.mant@quintiles.com

• Sponsor organisation

  AstraZeneca AB

• Eudract number

  2013-002757-30

• REC name

  HSC REC B

• REC reference

  13/NI/0142

• Date of REC Opinion

  14 Oct 2013

• REC opinion

  Further Information Favourable Opinion